Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study (Q44696806)
Jump to navigation
Jump to search
scientific article published on 10 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study |
scientific article published on 10 October 2014 |
Statements
1 reference
Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study (English)
1 reference
1 reference
1 reference
Laurent Peyrin-Biroulet
1 reference
Silvio Danese
1 reference
Janusz Rudziński
1 reference
Wolfgang Brandt
1 reference
Jean-Louis Dupas
1 reference
Yoram Bouhnik
1 reference
Dariusz Kleczkowski
1 reference
Peter Uebel
1 reference
Mikael Knutsson
1 reference
Fredrik Erlandsson
1 reference
Mark Berner Hansen
1 reference
10 October 2014
1 reference
1 reference
64
1 reference
2
1 reference
243-249
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference